JPH0550295B2 - - Google Patents

Info

Publication number: JPH0550295B2
Authority: JP; Japan
Prior art keywords: detergent; tissue; solution; graft; sterile
Prior art date: 1983-06-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP59502264A

Other languages

English (en)

Japanese (ja)

Other versions

JPS60501540A (ja

Inventor

Kurausu Burenderu

Reimondo Shii Deyuhameru

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University Patents Inc

Original Assignee

University Patents Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-06-10

Filing date

1984-05-24

Publication date

1993-07-28

1984-05-24 Application filed by University Patents Inc filed Critical University Patents Inc

1985-09-19 Publication of JPS60501540A publication Critical patent/JPS60501540A/ja

1993-07-28 Publication of JPH0550295B2 publication Critical patent/JPH0550295B2/ja

Status Granted legal-status Critical Current

Links

239000003599 detergent Substances 0.000 description 103
238000000034 method Methods 0.000 description 70
210000001519 tissue Anatomy 0.000 description 62
239000000243 solution Substances 0.000 description 53
210000002744 extracellular matrix Anatomy 0.000 description 30
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 26
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 26
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
239000000463 material Substances 0.000 description 23
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
239000007943 implant Substances 0.000 description 20
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 20
230000002792 vascular Effects 0.000 description 20
238000011282 treatment Methods 0.000 description 19
102000008186 Collagen Human genes 0.000 description 16
108010035532 Collagen Proteins 0.000 description 16
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 16
229920001436 collagen Polymers 0.000 description 16
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
210000000515 tooth Anatomy 0.000 description 13
229920004890 Triton X-100 Polymers 0.000 description 12
239000013504 Triton X-100 Substances 0.000 description 12
210000001367 artery Anatomy 0.000 description 12
210000000170 cell membrane Anatomy 0.000 description 12
239000011159 matrix material Substances 0.000 description 12
241000282472 Canis lupus familiaris Species 0.000 description 11
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 11
241001465754 Metazoa Species 0.000 description 11
210000000988 bone and bone Anatomy 0.000 description 11
210000000633 nuclear envelope Anatomy 0.000 description 11
239000004365 Protease Substances 0.000 description 10
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 10
150000002632 lipids Chemical class 0.000 description 10
102000004169 proteins and genes Human genes 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
238000002054 transplantation Methods 0.000 description 10
210000003954 umbilical cord Anatomy 0.000 description 10
238000005406 washing Methods 0.000 description 10
102000016911 Deoxyribonucleases Human genes 0.000 description 9
108010053770 Deoxyribonucleases Proteins 0.000 description 9
241000282412 Homo Species 0.000 description 9
108091005804 Peptidases Proteins 0.000 description 9
102000035195 Peptidases Human genes 0.000 description 8
210000001715 carotid artery Anatomy 0.000 description 8
238000004132 cross linking Methods 0.000 description 8
230000001086 cytosolic effect Effects 0.000 description 8
239000012153 distilled water Substances 0.000 description 8
210000003017 ductus arteriosus Anatomy 0.000 description 8
238000002513 implantation Methods 0.000 description 8
239000000137 peptide hydrolase inhibitor Substances 0.000 description 8
210000002469 basement membrane Anatomy 0.000 description 7
239000000834 fixative Substances 0.000 description 7
210000004379 membrane Anatomy 0.000 description 7
239000012528 membrane Substances 0.000 description 7
150000007523 nucleic acids Chemical class 0.000 description 7
102000039446 nucleic acids Human genes 0.000 description 7
108020004707 nucleic acids Proteins 0.000 description 7
238000001356 surgical procedure Methods 0.000 description 7
210000003041 ligament Anatomy 0.000 description 6
230000010412 perfusion Effects 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
206010002091 Anaesthesia Diseases 0.000 description 5
241000283690 Bos taurus Species 0.000 description 5
HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 5
230000037005 anaesthesia Effects 0.000 description 5
210000000845 cartilage Anatomy 0.000 description 5
238000005520 cutting process Methods 0.000 description 5
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 5
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 5
238000000605 extraction Methods 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
238000003860 storage Methods 0.000 description 5
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
230000003872 anastomosis Effects 0.000 description 4
238000011888 autopsy Methods 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
230000006870 function Effects 0.000 description 4
238000007654 immersion Methods 0.000 description 4
210000003205 muscle Anatomy 0.000 description 4
230000000704 physical effect Effects 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000008569 process Effects 0.000 description 4
238000012545 processing Methods 0.000 description 4
230000008439 repair process Effects 0.000 description 4
238000001223 reverse osmosis Methods 0.000 description 4
239000012266 salt solution Substances 0.000 description 4
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 4
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
102000016942 Elastin Human genes 0.000 description 3
108010014258 Elastin Proteins 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 3
238000011887 Necropsy Methods 0.000 description 3
QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 3
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
241000282887 Suidae Species 0.000 description 3
229960001138 acetylsalicylic acid Drugs 0.000 description 3
150000001335 aliphatic alkanes Chemical class 0.000 description 3
-1 amine salts Chemical class 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000017531 blood circulation Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
125000004432 carbon atom Chemical group C* 0.000 description 3
238000004140 cleaning Methods 0.000 description 3
229940009976 deoxycholate Drugs 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
229920002549 elastin Polymers 0.000 description 3
239000012634 fragment Substances 0.000 description 3
210000003709 heart valve Anatomy 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
210000003516 pericardium Anatomy 0.000 description 3
229920000056 polyoxyethylene ether Polymers 0.000 description 3
230000002980 postoperative effect Effects 0.000 description 3
230000010410 reperfusion Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
238000002791 soaking Methods 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
239000011734 sodium Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000007858 starting material Substances 0.000 description 3
125000003396 thiol group Chemical group [H]S* 0.000 description 3
210000001685 thyroid gland Anatomy 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
241000282465 Canis Species 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
241001269524 Dura Species 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
229920001214 Polysorbate 60 Polymers 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
150000008051 alkyl sulfates Chemical class 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
230000002146 bilateral effect Effects 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
230000001680 brushing effect Effects 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
230000002490 cerebral effect Effects 0.000 description 2
210000000038 chest Anatomy 0.000 description 2
238000000576 coating method Methods 0.000 description 2
210000000795 conjunctiva Anatomy 0.000 description 2
238000004925 denaturation Methods 0.000 description 2
230000036425 denaturation Effects 0.000 description 2
229960003964 deoxycholic acid Drugs 0.000 description 2
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
239000000645 desinfectant Substances 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
238000001493 electron microscopy Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
229910052588 hydroxylapatite Inorganic materials 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
230000002262 irrigation Effects 0.000 description 2
238000003973 irrigation Methods 0.000 description 2
229960003299 ketamine Drugs 0.000 description 2
VCMGMSHEPQENPE-UHFFFAOYSA-N ketamine hydrochloride Chemical compound [Cl-].C=1C=CC=C(Cl)C=1C1([NH2+]C)CCCCC1=O VCMGMSHEPQENPE-UHFFFAOYSA-N 0.000 description 2
YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 2
238000005259 measurement Methods 0.000 description 2
210000000713 mesentery Anatomy 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
239000011707 mineral Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
210000004940 nucleus Anatomy 0.000 description 2
210000002747 omentum Anatomy 0.000 description 2
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
229960001412 pentobarbital Drugs 0.000 description 2
230000035699 permeability Effects 0.000 description 2
235000021317 phosphate Nutrition 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229940051841 polyoxyethylene ether Drugs 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
238000002271 resection Methods 0.000 description 2
210000000813 small intestine Anatomy 0.000 description 2
150000003460 sulfonic acids Chemical class 0.000 description 2
231100000732 tissue residue Toxicity 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 description 1
CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 1
IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
206010002329 Aneurysm Diseases 0.000 description 1
108010001478 Bacitracin Proteins 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
206010006803 Burns third degree Diseases 0.000 description 1
241000283086 Equidae Species 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
108090000270 Ficain Proteins 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
241001494479 Pecora Species 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000288906 Primates Species 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
ULRQJNITUNNDBO-UHFFFAOYSA-N Steryl sulfate Chemical class C1CC2C3CCC(OS(=O)(=O)O)CC3CCC2C2CCCC21 ULRQJNITUNNDBO-UHFFFAOYSA-N 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
ZUBJEHHGZYTRPH-KTKRTIGZSA-N [(z)-octadec-9-enyl] hydrogen sulfate Chemical class CCCCCCCC\C=C/CCCCCCCCOS(O)(=O)=O ZUBJEHHGZYTRPH-KTKRTIGZSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
125000002947 alkylene group Chemical class 0.000 description 1
230000004075 alteration Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
210000002565 arteriole Anatomy 0.000 description 1
229960003071 bacitracin Drugs 0.000 description 1
229930184125 bacitracin Natural products 0.000 description 1
CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
239000000022 bacteriostatic agent Substances 0.000 description 1
229940064804 betadine Drugs 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000033558 biomineral tissue development Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229940080284 cetyl sulfate Drugs 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000010382 chemical cross-linking Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000004087 circulation Effects 0.000 description 1
239000002442 collagenase inhibitor Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 1
MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 1
238000002224 dissection Methods 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
239000012154 double-distilled water Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000001174 endocardium Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
235000019836 ficin Nutrition 0.000 description 1
POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000002637 fluid replacement therapy Methods 0.000 description 1
229910052587 fluorapatite Inorganic materials 0.000 description 1
239000006260 foam Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000002439 hemostatic effect Effects 0.000 description 1
LPTIRUACFKQDHZ-UHFFFAOYSA-N hexadecyl sulfate;hydron Chemical class CCCCCCCCCCCCCCCCOS(O)(=O)=O LPTIRUACFKQDHZ-UHFFFAOYSA-N 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
239000002655 kraft paper Substances 0.000 description 1
229960004194 lidocaine Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
239000000693 micelle Substances 0.000 description 1
210000004088 microvessel Anatomy 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
KKXWPVVBVWBKBL-UHFFFAOYSA-N n,n-diethylethanamine;dodecyl hydrogen sulfate Chemical compound CC[NH+](CC)CC.CCCCCCCCCCCCOS([O-])(=O)=O KKXWPVVBVWBKBL-UHFFFAOYSA-N 0.000 description 1
230000001453 nonthrombogenic effect Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229920002113 octoxynol Polymers 0.000 description 1
206010033675 panniculitis Diseases 0.000 description 1
239000000123 paper Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
229940056360 penicillin g Drugs 0.000 description 1
229960002275 pentobarbital sodium Drugs 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000000049 pigment Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
238000005498 polishing Methods 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
239000000047 product Substances 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000003134 recirculating effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002207 retinal effect Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000003001 serine protease inhibitor Substances 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical class CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
229950005425 sodium myristyl sulfate Drugs 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
210000004003 subcutaneous fat Anatomy 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000003356 suture material Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000001648 tannin Substances 0.000 description 1
229920001864 tannin Polymers 0.000 description 1
235000018553 tannin Nutrition 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000002885 thrombogenetic effect Effects 0.000 description 1
210000003781 tooth socket Anatomy 0.000 description 1
229940125725 tranquilizer Drugs 0.000 description 1
239000003204 tranquilizing agent Substances 0.000 description 1
230000002936 tranquilizing effect Effects 0.000 description 1
210000005239 tubule Anatomy 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000010246 ultrastructural analysis Methods 0.000 description 1
238000007631 vascular surgery Methods 0.000 description 1
239000002699 waste material Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)

JP59502264A 1983-06-10 1984-05-24 細胞外マトリクスの体移植片並びに該移植片の製造及び使用のための手段及び方法 Granted JPS60501540A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US50320383A	1983-06-10	1983-06-10
US503,203		1983-06-10
US582,504		1984-02-22

Publications (2)

Publication Number	Publication Date
JPS60501540A JPS60501540A (ja)	1985-09-19
JPH0550295B2 true JPH0550295B2 (fr)	1993-07-28

Family

ID=24001137

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP59502264A Granted JPS60501540A (ja)	1983-06-10	1984-05-24	細胞外マトリクスの体移植片並びに該移植片の製造及び使用のための手段及び方法

Country Status (2)

Country	Link
JP (1)	JPS60501540A (fr)
ZA (1)	ZA843751B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2598423B1 (fr) *	1985-03-01	1989-03-17	Inst Nat Sante Rech Med	Produit a base d'elastine, procede pour sa preparation et ses applications biologiques, en particulier en tant que biomateriaux et supports artificiels
JP5893563B2 (ja) *	2009-10-07	2016-03-23	ケレシス・イーエイチエフＫｅｒｅｃｉｓＥｈｆ	創傷ケア及び／又は他の組織治癒適用のための骨格材料
US20160058910A1 (en)	2013-05-07	2016-03-03	Natiional University Corporation Tokyo Medical And Dental University	Method for preparing particulate decellularized tissue
JP6271299B2 (ja) *	2014-02-28	2018-01-31	株式会社Adeka	脱細胞組織の製造方法
CN107249656A (zh)	2015-02-27	2017-10-13	Adeka株式会社	脱细胞化组织
CN107530476A (zh)	2015-03-12	2018-01-02	般财团法人化学及血清疗法研究所	使用脱细胞化组织的抗粘连材料和代用生物膜
WO2018221402A1 (fr)	2017-05-30	2018-12-06	哲哉樋上	Procédé de production de matériau décellularisé pour transplantation et composition de greffe comprenant un matériau biocompatible comprenant ledit matériau

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3649163A (en) *	1968-03-25	1972-03-14	American Cyanamid Co	Method for removing noncollagenous matter from mammalian gut
US3777599A (en) *	1971-08-23	1973-12-11	Burn Treatment Skin Bank Inc	Process for producing split-thickness animal skin for protecting flayed human tissue
JPS51124094A (en) *	1975-04-10	1976-10-29	Yeda Res & Dev	Method of providing explant
JPS521011A (en) *	1975-01-23	1977-01-06	Dardik Irving I	Nonnantigenic * nonnthrombogenic * dyessresistant transplant from umbilkal cord and its preparation and usage
US4239492A (en) *	1979-06-14	1980-12-16	Beisang Arthur A	Method of preparing vascular grafts of human and other umbilical cord origins for tissue ingrowth
US4352887A (en) *	1979-10-29	1982-10-05	Albert Einstein College Of Medicine Of Yeshiva University	Method and article for culturing differentiated cells
JPS57190555A (en) *	1981-04-30	1982-11-24	Extracorporeal Medical	Anti-carcarous tissue for transplantation

1984
- 1984-05-17 ZA ZA843751A patent/ZA843751B/xx unknown
- 1984-05-24 JP JP59502264A patent/JPS60501540A/ja active Granted

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3649163A (en) *	1968-03-25	1972-03-14	American Cyanamid Co	Method for removing noncollagenous matter from mammalian gut
US3777599A (en) *	1971-08-23	1973-12-11	Burn Treatment Skin Bank Inc	Process for producing split-thickness animal skin for protecting flayed human tissue
JPS521011A (en) *	1975-01-23	1977-01-06	Dardik Irving I	Nonnantigenic * nonnthrombogenic * dyessresistant transplant from umbilkal cord and its preparation and usage
JPS51124094A (en) *	1975-04-10	1976-10-29	Yeda Res & Dev	Method of providing explant
US4239492A (en) *	1979-06-14	1980-12-16	Beisang Arthur A	Method of preparing vascular grafts of human and other umbilical cord origins for tissue ingrowth
US4352887A (en) *	1979-10-29	1982-10-05	Albert Einstein College Of Medicine Of Yeshiva University	Method and article for culturing differentiated cells
JPS57190555A (en) *	1981-04-30	1982-11-24	Extracorporeal Medical	Anti-carcarous tissue for transplantation

Also Published As

Publication number	Publication date
JPS60501540A (ja)	1985-09-19
ZA843751B (en)	1984-12-24

Publication	Publication Date	Title
US4801299A (en)	1989-01-31	Body implants of extracellular matrix and means and methods of making and using such implants
JP6728307B2 (ja)	2020-07-22	組織製品の酵素処理方法
ES2231984T3 (es)	2005-05-16	Limpieza quimica de material biologico.
JP5142437B2 (ja)	2013-02-13	組織移植片
CA2173547C (fr)	2000-10-17	Substances membraneuses brutes pour produits medicaux; methode de preparation
US9936688B2 (en)	2018-04-10	Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
JP5015376B2 (ja)	2012-08-29	プロテオグリカンを減少させた軟組織異種移植片
JP6480911B2 (ja)	2019-03-13	組織移植片の脱細胞化方法
JPH09502379A (ja)	1997-03-11	天然組織の改良された架橋
JPH0550295B2 (fr)	1993-07-28
CN115461095A (zh)	2022-12-09	一种用于生产脱细胞组织支架的方法
Strömberg et al.	1977	An experimental study of autologous digital tendon transplants in the horse
JP5610268B2 (ja)	2014-10-22	高張電解質溶液による生体組織の脱細胞化処理方法
AU2016366404A1 (en)	2018-06-14	Methods and systems for stiffening of tissue for improved processing
Sokol et al.	2020	Prospects for application of bovine pericardial scaffold for cardial surgery
AU774997B2 (en)	2004-07-15	Chemical cleaning of biological material
MXPA99010251A (es)	2000-06-01	Limpieza quimica de material biologico

Legal Events

Date	Code	Title	Description
2004-05-24	EXPY	Cancellation because of completion of term